More than half of the elderly have already been vaccinated against flu in the current flu season, according to data from the "vakogenometer", released today.
"Graftoner" is a project launched in 2009 that allows the monitoring of the flu vaccine status in priority groups recommended by the General Health Administration (DGS) in real-time.
Among the groups recommended by DGS, the rate of vaccination is 40%, according to the "cimetometer" data reported on Tuesday, November 20, and to which agency Lus has access.
A group of people over the age of 65 has the highest vaccine coverage, with the vaccine 52.9% of people.
Following is a group of chronic patients, with 40.7% of people already vaccinated in this influenza season.
Health professionals have a 38% vaccination rate.
DGS also recommends a vaccine for people between the ages of 60 and 64, in which case the vaccination rate is 23%.
Women vaccinated more than men, with rates of 40% and 28% among the population surveyed, including priority vaccination groups.
According to the "gooncometer", less than 10% of the population surveyed were vaccinated this year for the first time against the flu.
Among those who have not been vaccinated, almost seven out of ten do not think they are going to be vaccinated.
Of those who have not been vaccinated, more than 46% said they did not do it because it was not a habit, and almost 30% indicated that they had not yet had the opportunity to do so.
The groups that evaluate the "vaccine gauge" are: persons over the age of 65, chronic illnesses, health professionals, and people aged between 60 and 64 years.
Influenza is a contagious disease that infects about 10% of adults and one third of children each year and usually has a benign course. However, it may have related complications, such as lung inflammation and decompensation of the underlying disease, especially in people with chronic illness or over 65 years of age.
A flu vaccine is free for people over 65 and can be taken without prescription in health centers. The vaccine is free for other groups, such as people with chronic obstructive pulmonary disease.